Fortify Your Brand Before Market Disruption Hits

The Strategic Case for Diversification

The 2025 federal spending bill introduces sweeping restrictions on hemp-derived supplements, creating unprecedented regulatory uncertainty for brands dependent on THC SKUs. Companies waiting for clarity risk operational paralysis, supply chain disruption, and revenue loss during critical market transitions.

Forward-thinking brands are taking a different approach: proactive diversification into functional mushrooms. This isn't retreat—it's strategic expansion into a high-growth wellness category with established regulatory frameworks and accelerating consumer adoption.

OSM provides the manufacturing infrastructure to execute this strategy without operational disruption. Whether you're reformulating existing products, launching parallel product lines, or pivoting entirely, we ensure business continuity while regulatory landscapes shift.

Regulatory Stability

Functional mushrooms operate within clear FDA and GMP compliance frameworks. No ambiguity, no pending legislation, no regulatory risk to product lines or distribution channels.

Proven Market Demand

The functional mushroom sector is experiencing double-digit annual growth, driven by increasing consumer awareness of adaptogenic wellness solutions and clinical research supporting efficacy claims.

Format Versatility

Mushroom formulations integrate seamlessly across delivery systems: gummies, tinctures, capsules, powders, beverages, and topicals—leveraging existing brand infrastructure and consumer preferences.

Stress Response Formula

Cortisol Modulation & Relaxation

Active Ingredients: Reishi, Chaga, L-Theanine, Ashwagandha, Magnesium Glycinate

Performance Formula

Mitochondrial Support & Endurance

Active Ingredients: Cordyceps Militaris, Lion's Mane, L-Carnitine, Taurine, Methylcobalamin B12

Sleep Architecture Formula

Circadian Regulation & Recovery

Active Ingredients: Reishi, Valerian Root Extract, Ashwagandha KSM-66, Lavender, 5-HTP